COVIFENZ Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for COVIFENZ with the United States Patent and Trademark Office. The USPTO has given the COVIFENZ trademark a serial number of 90112570. The federal status of this trademark filing is REGISTERED as of Tuesday, March 8, 2022. This trademark is owned by Medicago inc.. The COVIFENZ trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccines for the prevention and treatment of SARS-COV2, COVID-19, and coronavirus diseases and disorders
covifenz

General Information

Serial Number90112570
Word MarkCOVIFENZ
Filing DateThursday, August 13, 2020
Status700 - REGISTERED
Status DateTuesday, March 8, 2022
Registration Number6662384
Registration DateTuesday, March 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesHuman vaccines for the prevention and treatment of SARS-COV2, COVID-19, and coronavirus diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedicago inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMontréal (Québec) H3B3V2
CA
Party NameMedicago inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA
Party NameMedicago inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA

Trademark Events

Event DateEvent Description
Friday, February 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 2, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, February 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 17, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, November 17, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 17, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, November 17, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, November 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 10, 2021ASSIGNED TO LIE
Friday, November 5, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 26, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 26, 2021INQUIRY TO SUSPENSION E-MAILED
Thursday, August 26, 2021SUSPENSION INQUIRY WRITTEN
Thursday, February 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 18, 2021LETTER OF SUSPENSION E-MAILED
Thursday, February 18, 2021SUSPENSION LETTER WRITTEN
Wednesday, February 17, 2021ASSIGNED TO EXAMINER
Thursday, September 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 17, 2020NEW APPLICATION ENTERED

Related Keywords

covifenz coronavirus diseases disorders covid sars vaccines prevention treatment human